Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry
Status unconfirmed
Conditions studied: Cholangiocarcinoma, Pancreatic Cancer, Bile Duct Cancer, Biliary Stricture, Bile Duct Obstruction
In brief
The objective of this protocol is to establish a multicenter registry to evaluate the impact of radiofrequency ablation in the management of patients with pancreatico-biliary disorders including malignancies.
Key facts
- Study ID
- NCT01439698
- Run by
- Weill Medical College of Cornell University
- People needed
- 200
- Starts
- 2011-09-01
- Expected to finish
- 2018-12-30
- Last updated by the study team
- 2017-02-20
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients who have undergone RFA for pancreaticobiliary disorders
- Above 18 years of age
You may not qualify if…
- Patients who have not undergone RFA
- Below 18 years of age
Where it is running
- Massachusetts General Hospital — Boston, Massachusetts, United States (enrolling)
- Weill Cornell Medical College — New York, New York, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.